筛选出 2 条数据

    品牌 产品 货期 价格 货号 规格 /
    抗肿瘤剂13010-47-4

    CAS号:13010-47-4

    品名:洛莫司汀lomustine

    中文别名:洛莫司丁;1-(2-氯乙基)-3-环己基-1-亚硝基脲;

    英文别名:1-chloroethyl-3-cyclohexyl-1-nitrosourea;Urea,N-(2-chloroethyl)-N‘-cyclohexyl-N-nitroso-;CeeNU;1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea;CINU;Lomustine;1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea;CCNU;Lomustina;Cecenu;Lomustinum;Belustine;

    分子式:C9H16ClN3O2

    分子量:233.695

    精确质量:233.093

    Psa:61.77

    RTECS号:YS4900000

    EINECS号:235-859-2

    MDL号:MFCD00012392

    外观与性状:黄色粉末

    密度:1.35 g/cm3

    熔点:88-90

    折射率:1.57

    储存条件:库房低温通风干燥,与食品原料分开存放

    蒸汽压:0.00142mmHg at 25°C

    安全说明:S53-S45

    危险类别码:R45

    海关编码:2924299090

    危险品运输编码:3249

    危险类别:6.1(a)

    包装等级:II

    危险品标志:T

    简介:Lomustine(INN),abbreviatedCCNU(originalbrandname(formerlyavailable)isCeeNU,nowmarketedasGleostine),isanalkylatingnitrosoureacompoundusedinchemotherapy.Itiscloselyrelatedtosemustineandisinthesamefamilyasstreptozotocin.Itisahighlylipid-solubledrugandthuscrossestheblood-brainbarrier.Thispropertymakesitidealfortreatingbraintumors,whichisitsprimaryuse.Lomustinehasalongtimetonadir(thetimewhenwhitebloodcellsreachtheirlowestnumber).

    用途:烷化剂类抗肿瘤药,本品脂溶性强,可通过血脑屏障,进入脑脊液,常用于脑部原发肿瘤(如成胶质细胞瘤)及继发性肿瘤;治疗实体瘤,如联合用药治疗胃癌、直肠癌及支气管肺癌、恶性淋巴瘤等。

     13010-47-4 详细信息

    抗肿瘤剂

    CAS号:13010-47-4

    品名:洛莫司汀lomustine

    中文别名:洛莫司丁;1-(2-氯乙基)-3-环己基-1-亚硝基脲;

    英文别名:1-chloroethyl-3-cyclohexyl-1-nitrosourea;Urea,N-(2-chloroethyl)-N‘-cyclohexyl-N-nitroso-;CeeNU;1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea;CINU;Lomustine;1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea;CCNU;Lomustina;Cecenu;Lomustinum;Belustine;

    分子式:C9H16ClN3O2

    分子量:233.695

    精确质量:233.093

    Psa:61.77

    RTECS号:YS4900000

    EINECS号:235-859-2

    MDL号:MFCD00012392

    外观与性状:黄色粉末

    密度:1.35 g/cm3

    熔点:88-90

    折射率:1.57

    储存条件:库房低温通风干燥,与食品原料分开存放

    蒸汽压:0.00142mmHg at 25°C

    安全说明:S53-S45

    危险类别码:R45

    海关编码:2924299090

    危险品运输编码:3249

    危险类别:6.1(a)

    包装等级:II

    危险品标志:T

    简介:Lomustine(INN),abbreviatedCCNU(originalbrandname(formerlyavailable)isCeeNU,nowmarketedasGleostine),isanalkylatingnitrosoureacompoundusedinchemotherapy.Itiscloselyrelatedtosemustineandisinthesamefamilyasstreptozotocin.Itisahighlylipid-solubledrugandthuscrossestheblood-brainbarrier.Thispropertymakesitidealfortreatingbraintumors,whichisitsprimaryuse.Lomustinehasalongtimetonadir(thetimewhenwhitebloodcellsreachtheirlowestnumber).

    用途:烷化剂类抗肿瘤药,本品脂溶性强,可通过血脑屏障,进入脑脊液,常用于脑部原发肿瘤(如成胶质细胞瘤)及继发性肿瘤;治疗实体瘤,如联合用药治疗胃癌、直肠癌及支气管肺癌、恶性淋巴瘤等。

    展开

    抗肿瘤剂13010-47-4
    Apollo 1-(2-Chloroethyl)-3-cyclohex... 1-(2-Chloroethyl)-3-cyclohex... 3-4周

     7700.00
    OR5087 /
    DNA损伤160003-66-7

    CAS号:160003-66-7

    品名:4-碘-3-硝基-苯甲酰胺4-Iodo-3-nitrobenzamide

    中文别名:3-硝基-4-碘苯甲酰胺;

    英文别名:Iniparib(BSI-201);4-iodo-3-nitrobenzamide;

    分子式:C7H5IN2O3

    分子量:292.031

    精确质量:291.934

    Psa:88.91

    MDL号:MFCD11110639

    密度:2.056g/cm3

    沸点:344.754ºC at 760 mmHg

    闪点:162.302ºC

    折射率:1.696

    蒸汽压:0mmHg at 25°C

    海关编码:2924299090

    信号词:Warning

    危险性防范说明:P305 + P351 + P338

    危险标志:GHS07

    危险性描述:H302; H319

    简介:Iniparib(previouslyBSI201)(4-iodo-3-nitrobenzamide)wasadrugcandidateforcancertreatment.ItwasoriginallybelievedtoactasanirreversibleinhibitorofPARP1(hence,aPARPinhibitor)andpossiblyotherenzymesthroughcovalentmodification,butitseffectsagainstPARPwerelaterdisproven.Itunderwentclinicaltrialsfortreatmentofsometypesofbreastcancer,butwasdiscontinuedafterdisappointingPhaseIIIclinicaltrials.

     160003-66-7 详细信息

    DNA损伤

    CAS号:160003-66-7

    品名:4-碘-3-硝基-苯甲酰胺4-Iodo-3-nitrobenzamide

    中文别名:3-硝基-4-碘苯甲酰胺;

    英文别名:Iniparib(BSI-201);4-iodo-3-nitrobenzamide;

    分子式:C7H5IN2O3

    分子量:292.031

    精确质量:291.934

    Psa:88.91

    MDL号:MFCD11110639

    密度:2.056g/cm3

    沸点:344.754ºC at 760 mmHg

    闪点:162.302ºC

    折射率:1.696

    蒸汽压:0mmHg at 25°C

    海关编码:2924299090

    信号词:Warning

    危险性防范说明:P305 + P351 + P338

    危险标志:GHS07

    危险性描述:H302; H319

    简介:Iniparib(previouslyBSI201)(4-iodo-3-nitrobenzamide)wasadrugcandidateforcancertreatment.ItwasoriginallybelievedtoactasanirreversibleinhibitorofPARP1(hence,aPARPinhibitor)andpossiblyotherenzymesthroughcovalentmodification,butitseffectsagainstPARPwerelaterdisproven.Itunderwentclinicaltrialsfortreatmentofsometypesofbreastcancer,butwasdiscontinuedafterdisappointingPhaseIIIclinicaltrials.

    展开

    DNA损伤160003-66-7
    Apollo Iniparib Inipari 3-4周

     3740.00
    BIFK0012 /
温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算
微信 ×

打开微信,点击底部的“发现”

使用“扫一扫”即可将网页分享至朋友圈